Literature DB >> 7962642

Immunophenotyping in the diagnosis of acute leukaemias. General Haematology Task Force of BCSH.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7962642      PMCID: PMC494929          DOI: 10.1136/jcp.47.9.777

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  10 in total

Review 1.  A classification of acute leukaemia for the 1990s.

Authors:  D Catovsky; E Matutes; V Buccheri; V Shetty; J Hanslip; N Yoshida; R Morilla
Journal:  Ann Hematol       Date:  1991-02       Impact factor: 3.673

2.  Early expression of MCS2 (CD13) in the cytoplasm of blast cells from acute myeloid leukaemia.

Authors:  M S Pombo de Oliveira; E Matutes; S Rani; R Morilla; D Catovsky
Journal:  Acta Haematol       Date:  1988       Impact factor: 2.195

Review 3.  Lineage promiscuity in hemopoietic differentiation and leukemia.

Authors:  M F Greaves; L C Chan; A J Furley; S M Watt; H V Molgaard
Journal:  Blood       Date:  1986-01       Impact factor: 22.113

4.  The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.

Authors:  G Janossy; E Coustan-Smith; D Campana
Journal:  Leukemia       Date:  1989-03       Impact factor: 11.528

5.  Contribution of immunophenotype to the classification and differential diagnosis of acute leukaemia.

Authors:  L C Chan; S M Pegram; M F Greaves
Journal:  Lancet       Date:  1985-03-02       Impact factor: 79.321

6.  Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO)

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1991-07       Impact factor: 6.998

7.  Cytoplasmic expression of the CD3 antigen as a diagnostic marker for immature T-cell malignancies.

Authors:  J J van Dongen; G W Krissansen; I L Wolvers-Tettero; W M Comans-Bitter; H J Adriaansen; H Hooijkaas; E R van Wering; C Terhorst
Journal:  Blood       Date:  1988-03       Impact factor: 22.113

8.  Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis.

Authors:  M F Greaves; G Janossy; J Peto; H Kay
Journal:  Br J Haematol       Date:  1981-06       Impact factor: 6.998

9.  The role of an anti-myeloperoxidase antibody in the diagnosis and classification of acute leukaemia: a comparison with light and electron microscopy cytochemistry.

Authors:  V Buccheri; V Shetty; N Yoshida; R Morilla; E Matutes; D Catovsky
Journal:  Br J Haematol       Date:  1992-01       Impact factor: 6.998

10.  The role of ultrastructural cytochemistry and monoclonal antibodies in clarifying the nature of undifferentiated cells in acute leukaemia.

Authors:  E Matutes; M Pombo de Oliveira; L Foroni; R Morilla; D Catovsky
Journal:  Br J Haematol       Date:  1988-06       Impact factor: 6.998

  10 in total
  3 in total

Review 1.  UK NEQAS for leucocyte immunophenotyping: the first 10 years.

Authors:  J T Reilly; D Barnett
Journal:  J Clin Pathol       Date:  2001-07       Impact factor: 3.411

Review 2.  Chemotherapy of childhood lymphoblastic leukaemia: the first 50 years.

Authors:  J Lilleyman
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

3.  Comparison of Immunohistochemistry, Cytochemistry, and Flow Cytometry in AML for Myeloperoxidase Detection.

Authors:  Ankur Ahuja; Seema Tyagi; Tulika Seth; Hara Prasad Pati; Gps Gahlot; Preeti Tripathi; Venkatesan Somasundaram; Renu Saxena
Journal:  Indian J Hematol Blood Transfus       Date:  2017-07-28       Impact factor: 0.900

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.